GYRE
Gyre Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
GYRE fundamentals
Gyre Therapeutics (GYRE) released its earnings on Nov 7, 2025: revenue was 30.56M (YoY +19.90%), missed estimates; EPS was 0.03 (YoY +200.00%), beat estimates.
Revenue / YoY
30.56M
+19.90%
EPS / YoY
0.03
+200.00%
Report date
Nov 7, 2025
EPS
Revenue
Revenue & Expenses
GYRE has released its 2025 Q3 earnings report, with revenue of 30.56M, reflecting a YoY change of 19.92%, and net profit of 5.94M, showing a YoY change of 107.84%. The Sankey diagram below clearly presents GYRE's revenue sources and cost distribution.
Key Indicators
Gyre Therapeutics (GYRE) key financial stats and ratios, covering profitability, financial health, and leverage.
Gyre Therapeutics (GYRE)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Gyre Therapeutics (GYRE)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Gyre Therapeutics (GYRE)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Gyre Therapeutics (GYRE) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Gyre Therapeutics (GYRE) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
Did Gyre Therapeutics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Gyre Therapeutics year over year?What is Gyre Therapeutics's latest dividend and current dividend yield?What does Gyre Therapeutics do and what are its main business segments?What guidance did Gyre Therapeutics's management provide for the next earnings period?What were the key takeaways from Gyre Therapeutics’s earnings call?What is Gyre Therapeutics's gross profit margin?What were the key takeaways from Gyre Therapeutics's earnings call?
